BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10723135)

  • 1. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
    Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
    Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
    Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
    Yang SX; Hewitt SM; Steinberg SM; Liewehr DJ; Swain SM
    Oncol Rep; 2007 Feb; 17(2):281-7. PubMed ID: 17203162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase.
    Jeffrey IW; Bushell M; Tilleray VJ; Morley S; Clemens MJ
    Cancer Res; 2002 Apr; 62(8):2272-80. PubMed ID: 11956083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells.
    Wen W; Ding J; Sun W; Wu K; Ning B; Gong W; He G; Huang S; Ding X; Yin P; Chen L; Liu Q; Xie W; Wang H
    Cancer Res; 2010 Mar; 70(5):2010-9. PubMed ID: 20179204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4E--from translation to transformation.
    Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
    Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc.
    Polunovsky VA; Rosenwald IB; Tan AT; White J; Chiang L; Sonenberg N; Bitterman PB
    Mol Cell Biol; 1996 Nov; 16(11):6573-81. PubMed ID: 8887686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor-independent expression of the gene encoding eukaryotic translation initiation factor 4E in transformed cell lines.
    Rosenwald IB
    Cancer Lett; 1995 Nov; 98(1):77-82. PubMed ID: 8529209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells.
    Prasad A; Park IW; Allen H; Zhang X; Reddy MV; Boominathan R; Reddy EP; Groopman JE
    Oncogene; 2009 Mar; 28(12):1518-28. PubMed ID: 19198627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
    Topisirovic I; Ruiz-Gutierrez M; Borden KL
    Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
    Yu Q; Ciemerych MA; Sicinski P
    Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of c-myc in regulation of translation initiation.
    Schmidt EV
    Oncogene; 2004 Apr; 23(18):3217-21. PubMed ID: 15094771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.
    Zhu N; Gu L; Findley HW; Zhou M
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1272-9. PubMed ID: 16112647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum.
    Liang ZQ; Wang X; Li LY; Wang Y; Chen RW; Chuang DM; Chase TN; Qin ZH
    J Neurosci Res; 2007 May; 85(6):1295-309. PubMed ID: 17385714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
    Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
    Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of translation in neoplastic transformation from a pathologist's point of view.
    Rosenwald IB
    Oncogene; 2004 Apr; 23(18):3230-47. PubMed ID: 15094773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.